SAN FRANCISCO: Theranos, a startup that touted a revolutionary new way to test blood, has revealed it is under scrutiny by US civil and criminal authorities.
Investigations by the US Attorney’s Office and the Securities and Exchange Commission are ongoing, with documents being requested from the California-based company, Theranos told partners in a memo, a copy of which was obtained by AFP on April 18.
